Overview

Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.

Status:
Unknown status

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to check whether development of depression as a side effect of interferon alpha treatment in chronic carriers of hepatitis C can be prevented by omega-3 fatty acids.

Phase:

Phase 2

Details

Lead Sponsor:

Bnai Zion Medical Center

Treatments:

Interferon-alpha
Interferons